Sanfer Farma, which recently celebrated its 80th anniversary -although it is actually on its 81st- announced another ace up its sleeve: the majority purchase of the Mexican laboratory Probiomed, a Mexican company owned by the Uribe family, with 50 years of experience, which has fundamentally dedicated to the manufacture of pharmaceutical products of biotechnological origin.
With this strategic purchase, Sanfer Farma complements its already extensive portfolio of products, in order to make treatments with the most recent clinical-pharmaceutical research available to doctors -and of course to patients- “through drugs with a high degree of quality and innovation.
In the same way, this acquisition means in fact the incursion of Sanfer in the area of biotechnology, which is a very important step. In other words, the company led by Ricardo Amtmann will seek to significantly reduce the technological dependence that our country has always had on biotech drugs, in addition to substituting imports and strengthening Probiomed’s current platform, so that its drugs are distributed in the rest of Latin America.
On the other hand, it is expected that in the short term, Sanfer Farma will carry out commercial and technology transfer agreements that will allow the arrival of state-of-the-art biotechnological products in Mexico.
With this strategic move, Sanfer is relaunching Probiomed in the market, with a new face to enter another stage with greater financial solvency for Probiomed, which had been in financial trouble for at least five years. So it seems like it’s a win-win for everyone.
The financial and operational operation was not easy, it took time to materialize, around two years, but in the end it was achieved. Congratulations.
Digibee arrives in Mexico
The company of Brazilian origin will provide solutions in our country that simplify the integration of systems and migration to the cloud, which can represent 50% of the cost of digital projects in companies.
Translating the above into common language is not easy. It is about enabling companies of all sizes to simplify the process of complex integrations into their critical systems quickly and securely.
Thus, Digibee launched its Enterprise Integration Platform as a Service (EiPaaS), which aims to make organizations develop their own digital ecosystems, with the purpose of unlocking access to data, according to their needs, to better plan and prepare for the changes that digital transformation implies.
The passage of time and the arrival of new technologies have caused companies to have countless technologies, systems, platforms, connections and technological tools working at the same time in a single internal ecosystem. For this reason, digital transformation is driving integration in organizations, especially as a result of the Covid-19 pandemic.
Digibee’s Integration Platform is designed to dramatically reduce the complexities of digital landscape integrations and extend the capabilities of businesses toward true digital transformation.
The main factors that prevent organizations from achieving higher levels of innovation are legacy architectures and systems, budget constraints, and a lack of qualified resources. According to Gartner, 50% of the total costs and time of a digital transformation are for the integration effort.
“Digibee quickly and safely simplifies the complexity of integration between critical systems in organizations, modernizing the integration architecture. Solutions from companies such as SAP, Oracle, Totvs, Salesforce, Microsoft, and dozens more, can connect up to 10 times faster with us”, said Isaul Esteva, Sales Manager of the firm from Rio de Janeiro.
He concluded: “Digibee’s integration platform uses a cloud-native architecture that leverages Kubernetes technology to provide secure, reliable, and scalable performance. This allows companies to have efficient interactions between cloud and on-premises workloads.”
the medicine cabinet
- Are UNAM medical students now guilty of following the instructions of the health authority during the pandemic? After the clarification of the Highest House of Studies, wouldn’t a public apology be prudent and even advisable? Would you expect it from “you know who”? “Neither do I”.